IP Library Granted Patent US 10,900,962
Granted Patent B2
US 10,900,962 · App. 15/642,393 · Granted Jan 26, 2021

Molecular nets and devices for capturing analytes including exosomes

Inventors: Emily A. Stein (San Leandro, CA); Bruce Phelps (Clayton, CA); Robert Place (Bethesda, MD); Dina Uzri (San Diego, CA)
Assignee: Sienna Cancer Diagnostics Inc.
G01N33/54353G01N33/545G01N33/54346G01N33/54393G01N33/569G01N33/56916G01N33/56938G01N33/56983G01N33/76B01L3/502753G01N33/56911G01N2333/59
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,900,962
App. No.
15/642,393
Granted
Jan 26, 2021
Kind
B2
Abstract

Disclosed is a covalently-linked multilayered three-dimensional matrix comprising capture molecules, linkers and spacers (referred to as a Molecular Net) for specific and sensitive analyte capture from a sample. Also disclosed herein is a Molecular Net comprising covalently-linked multilayered three-dimensional matrix comprising more than one type of capture molecule and more than one type of linker and may comprise one or more spacer for specific and sensitive capture of more than one type of analyte from a sample. A Molecular Net may comprise a pseudorandom nature. Use of various capture molecules, linkers and spacers in a Molecular Net may confer unique binding properties to a Molecular Net. Porosity, binding affinity, size exclusion abilities, filtration abilities, concentration abilities and signal amplification abilities of a Molecular Net may be varied and depend on the nature of components used in its fabrication. Uses of a Molecular Net may include analyte capture, analyte enrichment, analyte purification, analyte detection, analyte measurement and analyte delivery. Molecular Nets may be used in liquid phase or on solid phases such as nanomaterials, modified metal surfaces, nanospheres, microspheres, microtiter plates, slides, pipettes, cassettes, cartridges, discs, probes, lateral flow devices, microfluidics devices, microfluidics devices, optical fibers and others.

Claims (72)

1. A composition comprising:

(a) a solid phase;

(b) a molecular net capable of binding to at least one analyte and coupled to at least a portion of a surface of the solid phase, the molecular net comprising more than one layer, which more than one layers comprise at least a first layer and a second layer, and each of the layers comprises capture molecules capable of specifically binding to the analyte(s); and,

(c) at least two different linker molecules,

wherein:

the capture molecules are coupled to each other within each layer by the at least two different linker molecules,

the molecular net is an internally covalently-linked three dimensional matrix,

the capture molecules within each layer can be of the same or different types,

the capture molecules of one layer can be of the same or different types as the capture molecules of another layer,

one of the at least one analyte is an exosome, and

the capture molecules comprise more than one antibodies directed to exosomes.

2. The composition of claim 1 , wherein the molecular net comprises three, four, five, or six layers.

3. The composition of claim 1 , wherein the capture molecules of each layer are different.

4. The composition of claim 1 , wherein the layers have different porosities from each other.

5. The composition of claim 1 , wherein each layer comprises at least one topological feature which affects the porosity of the layer.

6. The composition of claim 5 , wherein the at least one topological feature comprises one or more of fissures, channels, pores, or pockets.

7. The composition of claim 1 , wherein the last constructed layer has a porosity that is greater than porosity of any other layer.

8. The composition of claim 1 , wherein the porosity increases from the first constructed layer to the last constructed layer.

9. The composition of claim 1 , wherein at least one of the more than one antibodies is a monoclonal antibody.

10. The composition of claim 1 , wherein the more than one antibodies are directed to (a) one or more exosome proteins, (b) one or more exosome lipids, (c) one or more exosome carbohydrates, or (d) combinations thereof.

11. The composition of claim 1 , wherein the more than one antibodies are directed to one or more exosome proteins.

12. The composition of claim 1 , wherein the capture molecules further comprise one or more of nucleic acid probes, enzymes, recombinant proteins, or peptides.

13. The composition of claim 1 , wherein the capture molecules of the first layer, the capture molecules of the second layer, or both, are also coupled to each other by a plurality of different types of spacer molecules.

14. The composition of claim 13 , wherein the spacer molecules comprise one or more of PEGs, polymers, nucleic acids, albumins, Fe regions, or peptides.

15. The composition of claim 14 , wherein at least one of the plurality of different types of spacer molecules give the molecular net at least one pore having a diameter of between 40 and 500 nm.

16. The composition of claim 1 , wherein each layer comprises at least one topological feature that affects the porosity of the layer, wherein the topological feature is a pore having a diameter of between 40 and 500 nm.

17. A device for capturing at least one analyte comprising

(1) a solid phase and

(2) a capture composition having a molecular net capable of binding to the at least one analyte and coupled to at least a portion of a surface of the solid phase, the capture composition comprising more than one layer, which more than one layers comprise at least a first layer and a second layer, and each of the layers comprises capture molecules capable of specifically binding to the analyte(s); and,

(c) at least two different linker molecules,

wherein:

the capture molecules are coupled to each other within each layer by the at least two different linker molecules,

the molecular net is an internally covalently-linked three dimensional matrix,

the capture molecules within each layer can be of the same or different types,

the capture molecules of one layer can be of the same or different types as the capture molecules of another layer,

one of the at least one analyte is an exosome, and

the capture molecules comprise more than one antibodies directed to exosomes.

18. The device of claim 17 , wherein the solid phase is made of one or more of a plastic, polymer, thin film, colloidal metal, silica, carbon nanotube, protein, carbohydrate, lipid, nucleic acid, cell, or tissue.

19. The device of claim 17 , wherein the solid phase comprises one or more of a nanomaterial, modified metal surface, nanosphere, microsphere, microtiter plate, slide, pipette, cassette, cartridge, disc, probe, lateral flow device, microfluidics device, or optical fiber.

20. The device of claim 17 , wherein the capture composition is prefabricated and absorbed to the surface of the solid phase.

21. The device of claim 17 , wherein the capture composition is covalently linked to the surface of the solid phase.

22. The device of claim 17 , wherein the capture composition is constructed directly on the surface of the solid phase.

23. The device of claim 17 , wherein the capture composition comprises more than one layer and the linker molecules of the first layer, the linker molecules of the second layer, or both, comprise one or more of homobifunctional, heterobifunctional, trifunctional, or multifunctional types.

24. The device of claim 17 , wherein the capture composition comprises more than one layer and the capture composition has at least one measurable characteristic that undergoes a change when the capture molecules of the first layer, the capture molecules of the second layer, or both, bind to at least one analyte.

25. The device of claim 24 , wherein the measurable characteristic comprises one or more of physical shape, height, density, fluorescence intensity, wavelength shift, vibrational frequency, absorbance, flexibility, refractiveness, conductance, impedance, resistance, melting temperature, denaturation temperature, or freezing temperature.

26. The device of claim 17 , wherein the solid phase comprises an underlayer and the capture composition is coupled to at least a portion of the underlayer.

27. The device of claim 26 , wherein the underlayer does not comprise capture molecules.

28. The device of claim 26 , wherein the underlayer does comprise capture molecules and the underlayer capture molecules are capable of binding to at least one analyte.

29. The device of claim 17 , wherein the capture composition comprises more than one layer and the first layer is closer to the solid phase than the second layer, and the first layer has a first porosity that is less than a second porosity of the second layer.

30. A method of measuring a quantity of at least one analyte in a sample, the method comprising:

exposing one or more devices of claim 17 to the sample; and

allowing at least some of at least one analyte to bind to the capture molecules of the capture compositions of one or more devices.

31. The method of claim 30 , wherein the capture composition comprises more than one layer.

32. The method of claim 30 , further comprising measuring a change in the sample.

33. The method of claim 32 , wherein measuring the change comprises using one or more of a photonic multichannel analyzer, spectrometer, magnetic resonance imager, magnetic field detector, optical fiber, glass pipette, circuit, fluorometer, spectroscopic analyzer, potentiostat, calorimeter, electrophoresis, flow cytometer, CCD camera, microscope, acoustic chamber, microphone, and luminometer.

34. The method of claim 30 , wherein the capture composition has at least one measurable characteristic that undergoes a change when the capture molecules bind to the analyte.

35. The method of claim 30 , further comprising measuring the change in the measurable characteristic of one or more capture compositions.

36. The method of claim 35 , wherein measuring the change comprises using one or more of a photonic multichannel analyzer, spectrometer, magnetic resonance imager, magnetic field detector, optical fiber, glass pipette, circuit, fluorometer, spectroscopic analyzer, potentiostat, calorimeter, electrophoresis, flow cytometer, CCD camera, microscope, acoustic chamber, microphone, and luminometer.

37. A method of manufacturing a device for capturing at least one analyte, the method comprising:

placing a capture composition having a molecular net on at least a portion of a surface of a solid phase, the capture composition capable of binding to the at least one analyte and coupled to at least a portion of a surface of the solid phase, the capture composition comprising more than one layer, which more than one layers comprise at least a first layer and a second layer, and each of the layers comprises capture molecules capable of specifically binding to the analyte(s); and,

(c) at least two different linker molecules,

wherein:

the capture molecules are coupled to each other within each layer by the at least two different linker molecules,

the molecular net is an internally covalently-linked three dimensional matrix,

the capture molecules within each layer can be of the same or different types,

the capture molecules of one layer can be of the same or different types as the capture molecules of another layer,

one of the at least one analyte is an exosome, and

the capture molecules comprise more than one antibodies directed to exosomes.

38. The method of claim 37 , wherein the capture composition comprises more than one layer.

39. The method of claim 37 , wherein the placing a capture composition comprises prefabricating the capture composition and absorbing the capture composition to the surface of the solid phase.

40. The method of claim 37 , wherein the placing a capture composition comprises covalently linking the capture composition to the surface of the solid phase.

41. The method of claim 37 , wherein the placing a capture composition includes constructing the capture composition directly on the surface of the solid phase.

Assignments (4)
CHANGE OF NAME Recorded Jun 6, 2022
From: SIENNA CANCER DIAGNOSTICS INC.
To: INOVIQ INC.
Reel/Frame 060283/0933 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 14, 2019
From: SEVIDENT INC.
To: SIENNA CANCER DIAGNOSTICS INC.
Reel/Frame 049469/0564 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 11, 2019
From: STEIN, EMILY; PHELPS, BRUCE; UZRI, DINA; PLACE, ROBERT
To: SEVIDENT INC.
Reel/Frame 049427/0102 →
RELEASE OF SECURITY INTEREST Recorded Feb 28, 2019
From: CANNER, NIKO
To: SEVIDENT, INC.
Reel/Frame 048465/0198 →
Continuity (16)
Continuation 14214556 · Mar 14, 2014
Continuation In Part 13938055 · Jul 9, 2013
Continuation In Part 13938055 · Jul 9, 2013
Continuation In Part 15642393
Continuation In Part 13511364 · Oct 7, 2012
Continuation In Part 13511364 · Oct 7, 2012
Continuation 13511364
Continuation 61410837 · Nov 5, 2010
Provisional Application 61783189 · Mar 14, 2013
Provisional Application 61669261 · Jul 9, 2012
Provisional Application 61669265 · Jul 9, 2012
Provisional Application 61343467 · Apr 29, 2010
Provisional Application 61340287 · Mar 15, 2010
Provisional Application 61337257 · Feb 1, 2010
Provisional Application 61281991 · Nov 24, 2009
Related Publication 20180143188A1 · May 24, 2018